Chief Operating Officer · Bolt Biotherapeutics, Inc. (BOLT)

Grant Yonehiro

A named executive officer of Bolt Biotherapeutics in every fiscal year CompBrief holds from FY2020 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$4,007,443

Salary $463,500Stock awards $168,300Bonus $139,100

FY2024: $948,414

2nd of 2 named executive officers at Bolt Biotherapeutics by FY2025 total.

2 named officers on file for Bolt Biotherapeutics, FY2025

Grant Yonehiro’s pay file — $29

  • 6 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Bolt Biotherapeutics’s whole pay program stands against its peers

  • Bolt Biotherapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BOLT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Grant Yonehiro’s full pay file as a PDF — free

More than this page: up to 10 years of Grant’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Grant Yonehiro compensation by year

Bolt Biotherapeutics Summary Compensation Table · all 6 fiscal years held
In US dollars, as Bolt Biotherapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023FY2024FY2025
Salary$309,000$370,000$386,650$415,050$443,138$463,500
Bonus$124,373$148,000$146,927$149,600$180,000$139,100
Stock awards$0$0$0$0$0$168,300
Option awards$138,130$1,501,451$424,061$274,854$325,276$3,236,543
Non-equity incentive$0$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0$0
All other$700$1,980$11,130$0$0$0
Total$572,203$2,021,431$968,768$839,504$948,414$4,007,443

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bolt Biotherapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-186923, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Bolt Biotherapeutics, Inc. filed document, accession 0001193125-26-186923. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

$572K
$2.0M
$969K
$840K
$948K
$4.0M
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU30,000$164,040—
Option4,241—$5.44
Option12,151—$5.44
Option316—$5.44
Option4,086—$5.44

Per the Outstanding Equity Awards at Fiscal Year-End table in Bolt Biotherapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

3 Form 4 lines since the FY2025 proxy (filed April 28, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-09-18Sale—6,850$3.2417,269
2026-09-17Sale—4,909$3.3224,119
2026-09-16Sale—1,417$3.7729,028

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Bolt Biotherapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
William QuinnPresident, Chief Executive Officer and Chief Financial Officer$4,558,368
Grant Yonehiro · this pageChief Operating Officer$4,007,443

The full Bolt Biotherapeutics compensation record

free company brief

This page is one person within Bolt Biotherapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Bolt Biotherapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Grant Yonehiro's compensation dossier · One-time report. No refunds.